Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ari M Melnick

Showing results (1-10 of 147) with videos related to

Pageof 15
Sort By:
Best Practice & Research. Clinical Haematology|December 7, 2010
Epigenetics in AMLAri M Melnick
Blood Cancer Discovery|August 2, 2022
Tee-ing up a New Follicular Lymphoma Classification SystemAri M Melnick
Blood Cancer Discovery|October 18, 2021
Non-oncogene Addiction to SIRT5 in Acute Myeloid LeukemiaMeng Li, Ari M Melnick
Blood|September 15, 2020
The dangers of déjà vu: memory B cells as the cells of origin of ABC-DLBCLsLeandro Venturutti, Ari M Melnick
Cancer Discovery|September 5, 2019
An "EZ" Epigenetic Road to Leukemia Stem Cell Metabolic Reprogramming?Meng Li, Ari M Melnick
Hematological Oncology|June 11, 2015
VII. Are lymphomas driven by epigenetic lesions?Isaac W Boss, Ari M Melnick
Leukemia & Lymphoma|November 16, 2021
Targeting MALT1 for the treatment of diffuse large B-cell lymphomaMadhav R Seshadri, Ari M Melnick
Current Opinion in Immunology|June 4, 2013
New effector functions and regulatory mechanisms of BCL6 in normal and malignant lymphocytesKaren L Bunting, Ari M Melnick
Current Opinion in Hematology|April 30, 2019
Role of chromosomal architecture in germinal center B cells and lymphomagenesisMartin A Rivas, Ari M Melnick
Epigenomics|July 20, 2016
Mutant IDH: a targetable driver of leukemic phenotypes linking metabolism, epigenetics and transcriptional regulationFrancine E Garrett-Bakelman, Ari M Melnick
Pageof 15

Showing results (1-10 of 147) with videos related to

Sort By:
Pageof 15
Best Practice & Research. Clinical Haematology|December 7, 2010
Epigenetics in AMLAri M Melnick
Blood Cancer Discovery|August 2, 2022
Tee-ing up a New Follicular Lymphoma Classification SystemAri M Melnick
Blood Cancer Discovery|October 18, 2021
Non-oncogene Addiction to SIRT5 in Acute Myeloid LeukemiaMeng Li, Ari M Melnick
Blood|September 15, 2020
The dangers of déjà vu: memory B cells as the cells of origin of ABC-DLBCLsLeandro Venturutti, Ari M Melnick
Cancer Discovery|September 5, 2019
An "EZ" Epigenetic Road to Leukemia Stem Cell Metabolic Reprogramming?Meng Li, Ari M Melnick
Hematological Oncology|June 11, 2015
VII. Are lymphomas driven by epigenetic lesions?Isaac W Boss, Ari M Melnick
Leukemia & Lymphoma|November 16, 2021
Targeting MALT1 for the treatment of diffuse large B-cell lymphomaMadhav R Seshadri, Ari M Melnick
Current Opinion in Immunology|June 4, 2013
New effector functions and regulatory mechanisms of BCL6 in normal and malignant lymphocytesKaren L Bunting, Ari M Melnick
Current Opinion in Hematology|April 30, 2019
Role of chromosomal architecture in germinal center B cells and lymphomagenesisMartin A Rivas, Ari M Melnick
Epigenomics|July 20, 2016
Mutant IDH: a targetable driver of leukemic phenotypes linking metabolism, epigenetics and transcriptional regulationFrancine E Garrett-Bakelman, Ari M Melnick
Pageof 15